Phase II study of personalized cancer vaccine in CRC shows positive preliminary PFS and long-term ctDNA data

UAMS Winthrop P. Rockefeller Cancer Institute, ARcare partner to boost CRC screenings in rural Arkansas

A new partnership between the University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute and ARcare aims to improve colorectal cancer screening rates in seven rural Arkansas counties where late-stage diagnoses and cancer disparities are on the rise.

July 25, 2025

Vol.51 No.29

Drugs & Targets

Braftovi combination receives approval in China for BRAFV600E-mutant metastatic colorectal cancer

Chinese authorities granted the marketing authorization for Braftovi (encorafenib) in combination with cetuximab, for the treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer, after prior systemic therapy.

July 18, 2025

Vol.51 No.28

Drugs & Targets

Personalis, Tempus AI expand commercial partnership focused on ultra-sensitive cancer recurrence testing

Personalis Inc. and Tempus AI Inc. have expanded and extended their strategic collaboration, adding a new indication, colorectal cancer, to the existing, exclusive commercialization agreement.

July 11, 2025

Vol.51 No.27

Capitol Hill

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

June 27, 2025

Vol.51 No.25

By Claire Marie Porter

Cancer Policy

RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay

Sen. Bill Cassidy (R-LA), a key Senate health leader, June 23 called for the meeting of the Advisory Committee on Immunization Practices to be delayed, citing concerns over the committee members’ lack of directly relevant experience and their potential bias against some vaccines.

June 27, 2025

Vol.51 No.25

By Claire Marie Porter and Jacquelyn Cobb

Cancer Policy

Vinay Prasad named chief medical and scientific officer at FDA

Vinay Prasad, a MAHA-aligned hematologist-oncologist with an avid cyber following, who was named director of the FDA Center for Biologics Evaluation and Research in early May (The Cancer Letter, May 9, 2025), has now been also appointed chief medical and science officer at FDA, according to an internal memo obtained by The Cancer Letter.

June 20, 2025

Vol.51 No.24

By Claire Marie Porter

Phase II study of personalized cancer vaccine in CRC shows positive preliminary PFS and long-term ctDNA data

YOU MAY BE INTERESTED IN

UAMS Winthrop P. Rockefeller Cancer Institute, ARcare partner to boost CRC screenings in rural Arkansas

Braftovi combination receives approval in China for BRAFV600E-mutant metastatic colorectal cancer

Personalis, Tempus AI expand commercial partnership focused on ultra-sensitive cancer recurrence testing

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”

RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay

Vinay Prasad named chief medical and scientific officer at FDA

Renew today!

Subscriber content

Never miss an issue!

Login

Phase II study of personalized cancer vaccine in CRC shows positive preliminary PFS and long-term ctDNA data

YOU MAY BE INTERESTED IN

UAMS Winthrop P. Rockefeller Cancer Institute, ARcare partner to boost CRC screenings in rural Arkansas

Braftovi combination receives approval in China for BRAFV600E-mutant metastatic colorectal cancer

Personalis, Tempus AI expand commercial partnership focused on ultra-sensitive cancer recurrence testing

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policiesRep. Lori Trahan: “People are going to die”

RFK Jr.’s new committee votes on vaccine recommendations, despite Sen. Cassidy’s call for meeting delay

Vinay Prasad named chief medical and scientific officer at FDA

Never miss an issue!

Login

At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die”